These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16612052)

  • 1. Cancer and pregnancy share similar mechanisms of immunological escape.
    Wilczyński JR
    Chemotherapy; 2006; 52(3):107-10. PubMed ID: 16612052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surface molecules on the trophoblast cells].
    Bjercke S
    Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1123-6. PubMed ID: 2024261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-classical HLA-G antigen and its role in the cancer progression.
    Tripathi P; Agrawal S
    Cancer Invest; 2006 Mar; 24(2):178-86. PubMed ID: 16537188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on HLA-G: an update.
    Favier B; LeMaoult J; Rouas-Freiss N; Moreau P; Menier C; Carosella ED
    Tissue Antigens; 2007 Mar; 69(3):207-11. PubMed ID: 17493143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen-G in cancer: are they clinically relevant?
    Yan WH
    Cancer Lett; 2011 Dec; 311(2):123-30. PubMed ID: 21843913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiology of the human placental trophoblast.
    Johnson PM
    Exp Clin Immunogenet; 1993; 10(2):118-22. PubMed ID: 8251180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do tumors actively escape from host immunosurveillance?
    Wilczyński JR; Duechler M
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):435-48. PubMed ID: 20922572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of HLA-E and -F in pregnancy.
    Ishitani A; Sageshima N; Hatake K
    J Reprod Immunol; 2006 Apr; 69(2):101-13. PubMed ID: 16487601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two individuals under the same skin--immune mechanisms in pregnancy].
    Austgulen R; Arntzen KJ
    Tidsskr Nor Laegeforen; 1999 Dec; 119(30):4468-71. PubMed ID: 10827486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G and its KIR ligands in cancer--another enigma yet to be solved?
    Urosevic M; Trojan A; Dummer R
    J Pathol; 2002 Mar; 196(3):252-3. PubMed ID: 11857486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen-G and cancer immunoediting.
    Urosevic M; Dummer R
    Cancer Res; 2008 Feb; 68(3):627-30. PubMed ID: 18245459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological recognition in pregnancy: physiology].
    Vinatier D; Monnier JC
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):709-21. PubMed ID: 8308197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
    Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
    Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape mechanisms in tumor immunity: a year 2000 update.
    Pawelec G; Heinzel S; Kiessling R; Müller L; Ouyang Q; Zeuthen J
    Crit Rev Oncog; 2000; 11(2):97-133. PubMed ID: 11005508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss--a review of literature of various therapeutic protocols.
    Shetty S; Ghosh K
    Am J Reprod Immunol; 2009 Jul; 62(1):9-24. PubMed ID: 19527228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species diversity in the immunogenetic relationship between mother and fetus: is trophoblast insusceptibility to immunological destruction the only essential common feature for the maintenance of allogeneic pregnancy?
    Billington WD
    Exp Clin Immunogenet; 1993; 10(2):73-84. PubMed ID: 8251182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options].
    Stremmel C; Klein P; Hohenberger W
    Chirurg; 2002 Mar; 73(3):255-61. PubMed ID: 11963500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.